AU6687486A – Solubilization of protein aggregates
– Google Patents
AU6687486A – Solubilization of protein aggregates
– Google Patents
Solubilization of protein aggregates
Info
Publication number
AU6687486A
AU6687486A
AU66874/86A
AU6687486A
AU6687486A
AU 6687486 A
AU6687486 A
AU 6687486A
AU 66874/86 A
AU66874/86 A
AU 66874/86A
AU 6687486 A
AU6687486 A
AU 6687486A
AU 6687486 A
AU6687486 A
AU 6687486A
Authority
AU
Australia
Prior art keywords
protein
solubilization
source
cationic surfactant
solubilisation
Prior art date
1985-12-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU66874/86A
Other versions
AU597924B2
(en
Inventor
Malcolm Roy Brandon
Joseph John Patroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATINCO NV
Original Assignee
Bunge Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1985-12-11
Filing date
1985-12-11
Publication date
1987-06-18
1985-12-11
Application filed by Bunge Australia Pty Ltd
filed
Critical
Bunge Australia Pty Ltd
1985-12-11
Priority to AU66874/86A
priority
Critical
patent/AU597924B2/en
1987-06-18
Publication of AU6687486A
publication
Critical
patent/AU6687486A/en
1990-06-14
Application granted
granted
Critical
1990-06-14
Publication of AU597924B2
publication
Critical
patent/AU597924B2/en
1993-07-22
Assigned to FIDELITY FOOD TECHNOLOGIES PTY. LTD.
reassignment
FIDELITY FOOD TECHNOLOGIES PTY. LTD.
Alteration of Name(s) in Register under S187
Assignors: BUNGE (AUSTRALIA) PTY LTD
1995-02-23
Assigned to SOUTHERN CROSS BIOTECH PTY LTD.
reassignment
SOUTHERN CROSS BIOTECH PTY LTD.
Alteration of Name(s) in Register under S187
Assignors: FIDELITY FOOD TECHNOLOGIES PTY. LTD.
2000-03-16
Assigned to NATINCO NV
reassignment
NATINCO NV
Alteration of Name(s) in Register under S187
Assignors: SOUTHERN CROSS BIOTECH PTY LTD.
2006-12-10
Anticipated expiration
legal-status
Critical
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
C07K14/445—Plasmodium
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/575—Hormones
C07K14/61—Growth hormones [GH] (Somatotropin)
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
C12N2720/00011—Details
C12N2720/10011—Birnaviridae
C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
Y02P20/00—Technologies relating to chemical industry
Y02P20/50—Improvements relating to the production of bulk chemicals
Y02P20/582—Recycling of unreacted starting or intermediate materials
Abstract
A source of proteins in insoluble form and a source of at least one cationic surfactant are provided. The insoluble protein is then treated with the cationic surfactant(s) in an amount sufficient to effect solubilisation without substantial modification to the structural backbone of the protein. The treatment is particularly applicable to the solubilisation and recovery of biologically active proteins synthesised by microorganisms and eukaryotic cell lines which have been modified by recombinant DNA technology.
AU66874/86A
1985-12-11
1985-12-11
Solubilization of protein aggregates
Expired
AU597924B2
(en)
Priority Applications (1)
Application Number
Priority Date
Filing Date
Title
AU66874/86A
AU597924B2
(en)
1985-12-11
1985-12-11
Solubilization of protein aggregates
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
AUPH3818
1985-12-11
AU66874/86A
AU597924B2
(en)
1985-12-11
1985-12-11
Solubilization of protein aggregates
AUPH381885
1985-12-11
Publications (2)
Publication Number
Publication Date
AU6687486A
true
AU6687486A
(en)
1987-06-18
AU597924B2
AU597924B2
(en)
1990-06-14
Family
ID=3771404
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU66874/86A
Expired
AU597924B2
(en)
1985-12-11
1985-12-11
Solubilization of protein aggregates
Country Status (14)
Country
Link
US
(1)
US4797474A
(en)
EP
(1)
EP0226448B1
(en)
JP
(1)
JPH0660198B2
(en)
CN
(1)
CN86108729A
(en)
AT
(1)
ATE76878T1
(en)
AU
(1)
AU597924B2
(en)
CA
(1)
CA1281849C
(en)
DE
(1)
DE3685562T2
(en)
DK
(1)
DK171331B1
(en)
ES
(1)
ES2032194T3
(en)
GR
(1)
GR3004903T3
(en)
MY
(1)
MY101204A
(en)
NO
(1)
NO864990L
(en)
NZ
(1)
NZ218586A
(en)
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU609824B2
(en)
*
1987-06-15
1991-05-09
Southern Cross Biotech Pty Ltd.
Production of proteins in active forms
DE10309691B4
(en)
2003-02-28
2018-10-04
Hans-Knöll-Institut für Naturstoff-Forschung e.V.
Recovery of soluble proteins from the biomass of recombinant microorganisms
Families Citing this family (35)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5037644A
(en)
*
1986-10-27
1991-08-06
Cetus Corporation
Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
AU612133B2
(en)
*
1987-02-20
1991-07-04
Natinco Nv
Production of proteins in active forms
CA1305285C
(en)
*
1987-04-21
1992-07-14
Malcolm Roy Brandon
Production of proteins in active forms
US4931543A
(en)
*
1987-05-11
1990-06-05
Cetus Corporation
Process for recovering microbially produced interleukin-2
US5654176A
(en)
*
1987-05-28
1997-08-05
Amrad Corporation Limited
Fusion proteins containing glutathione-s-transferase
EP0295859B1
(en)
*
1987-06-15
1994-11-17
Southern Cross Biotech Pty.Ltd.
Production of proteins in active forms
US5266205A
(en)
*
1988-02-04
1993-11-30
Battelle Memorial Institute
Supercritical fluid reverse micelle separation
US5637566A
(en)
*
1988-08-24
1997-06-10
Southern Cross Biotech Pty. Ltd.
Method of improving carcass quality by administering growth hormone
US5136027A
(en)
*
1989-05-02
1992-08-04
Abbott Laboratories
Method for renaturing proteins in the presence of alkyl sulfate detergents
DE69122280T2
(en)
*
1990-03-01
1997-04-24
Hewlett Packard Co
Minimization of eluate bandwidths in liquid chromatography
US5530100A
(en)
*
1990-05-07
1996-06-25
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Methods for purification of recombinantly produced proteins
EP0529201B1
(en)
*
1991-08-26
1997-09-24
Hewlett-Packard Company
Chromatographic method with micellar on-column enrichment
US5252216A
(en)
*
1992-03-24
1993-10-12
Smithkline Beecham Corporation
Protein purification
EP0920306A2
(en)
1996-07-12
1999-06-09
Leukosite, Inc.
Chemokine receptor antagonists and methods of use therefor
ZA9711733B
(en)
*
1996-12-31
1998-07-01
Monsanto Co
Method for solubilization and naturation of somatotropins
US20020052026A1
(en)
*
1997-10-08
2002-05-02
Steven M. Vicik
Methods of refolding proteins
CA2728907C
(en)
1998-08-06
2015-11-24
Mountain View Pharmaceuticals, Inc.
Peg-urate oxidase conjugates and use thereof
US7319021B2
(en)
*
2002-11-01
2008-01-15
Promega Corporation
Cell lysis composition, methods of use, apparatus and kit
US8148123B2
(en)
2005-04-11
2012-04-03
Savient Pharmaceuticals, Inc.
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US20080159976A1
(en)
*
2005-04-11
2008-07-03
Jacob Hartman
Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
TWI418564B
(en)
*
2005-04-11
2013-12-11
Savient Pharmaceuticals Inc
Purification of proteins with cationic surfactant
CN101198693B
(en)
2005-04-11
2013-03-27
萨文特医药公司
Variant forms of urate oxidase and use thereof
HU229626B1
(en)
*
2005-04-11
2014-03-28
Savient Pharmaceuticals
A variant form of urate oxidase and use thereof
WO2006125452A1
(en)
*
2005-05-23
2006-11-30
Universite De Geneve
Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
US20100221747A1
(en)
*
2005-12-14
2010-09-02
Denka Seiken Co., Ltd.
Immunochromatography detection of multidrug-resistant staphylococcus and diagnostic kit
PL2013225T3
(en)
*
2006-04-12
2015-06-30
Crealta Pharmaceuticals Llc
Purification of proteins with cationic surfactant
WO2008034016A2
(en)
*
2006-09-15
2008-03-20
Foldrx Pharmaceuticals, Inc.
Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
US9706787B2
(en)
*
2007-10-05
2017-07-18
Advance International Inc.
Systems and methods for deriving protein powder
US8663725B2
(en)
*
2007-10-05
2014-03-04
Advance International Inc.
Method for deriving a high-protein powder/ omega 3 oil and double distilled water from any kind of fish or animal ( protein)
SG176897A1
(en)
2009-06-25
2012-01-30
Savient Pharmaceuticals Inc
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
EP2855502B1
(en)
2012-05-31
2019-06-26
Agency For Science, Technology And Research
Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
US9826757B2
(en)
2013-03-15
2017-11-28
Advance International Inc.
Automated method and system for recovering protein powder meal, pure omega 3 oil and purified distilled water from animal tissue
JP6147340B2
(en)
*
2013-05-29
2017-06-14
Jsr株式会社
Cleaning composition, protein purification method, and protein
WO2015130223A1
(en)
2014-02-27
2015-09-03
Agency For Science, Technology And Research
Methods for reducing chromatin content in protein preparations by treatment with alkyl cations
JP6984828B2
(en)
*
2017-11-22
2021-12-22
学校法人東京薬科大学
Aggregated protein regenerating agent and method for regenerating aggregated protein using this
Family Cites Families (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
DE2829089A1
(en)
*
1977-07-13
1979-02-01
Sandoz Ag
SUBUNIT VACCINE
US4462940A
(en)
*
1982-09-23
1984-07-31
Cetus Corporation
Process for the recovery of human β-interferon-like polypeptides
US4659568A
(en)
*
1985-02-27
1987-04-21
American Cyanamid Company
Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
US4656255A
(en)
*
1985-09-09
1987-04-07
International Minerals & Chemical Corp.
Protein recovery
ATE60595T1
(en)
*
1986-07-28
1991-02-15
Allied Signal Inc
SULPHONATED BENZOTRIAZOLE AND THEIR USE IN POLYAMIDES.
1985
1985-12-11
AU
AU66874/86A
patent/AU597924B2/en
not_active
Expired
1986
1986-12-09
US
US06/939,578
patent/US4797474A/en
not_active
Expired – Lifetime
1986-12-10
DK
DK592186A
patent/DK171331B1/en
not_active
IP Right Cessation
1986-12-10
AT
AT86309603T
patent/ATE76878T1/en
not_active
IP Right Cessation
1986-12-10
NO
NO864990A
patent/NO864990L/en
unknown
1986-12-10
ES
ES198686309603T
patent/ES2032194T3/en
not_active
Expired – Lifetime
1986-12-10
CA
CA000524987A
patent/CA1281849C/en
not_active
Expired – Lifetime
1986-12-10
DE
DE8686309603T
patent/DE3685562T2/en
not_active
Expired – Lifetime
1986-12-10
NZ
NZ218586A
patent/NZ218586A/en
unknown
1986-12-10
EP
EP86309603A
patent/EP0226448B1/en
not_active
Expired – Lifetime
1986-12-11
MY
MYPI86000197A
patent/MY101204A/en
unknown
1986-12-11
CN
CN198686108729A
patent/CN86108729A/en
active
Pending
1986-12-11
JP
JP61295714A
patent/JPH0660198B2/en
not_active
Expired – Fee Related
1992
1992-06-11
GR
GR920401248T
patent/GR3004903T3/el
unknown
Cited By (2)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU609824B2
(en)
*
1987-06-15
1991-05-09
Southern Cross Biotech Pty Ltd.
Production of proteins in active forms
DE10309691B4
(en)
2003-02-28
2018-10-04
Hans-Knöll-Institut für Naturstoff-Forschung e.V.
Recovery of soluble proteins from the biomass of recombinant microorganisms
Also Published As
Publication number
Publication date
DK592186D0
(en)
1986-12-10
DE3685562D1
(en)
1992-07-09
ES2032194T3
(en)
1993-01-16
EP0226448B1
(en)
1992-06-03
DE3685562T2
(en)
1992-12-24
CA1281849C
(en)
1991-03-19
AU597924B2
(en)
1990-06-14
EP0226448A3
(en)
1989-01-11
US4797474A
(en)
1989-01-10
NZ218586A
(en)
1989-07-27
MY101204A
(en)
1991-08-17
NO864990L
(en)
1987-06-12
JPH0660198B2
(en)
1994-08-10
ATE76878T1
(en)
1992-06-15
EP0226448A2
(en)
1987-06-24
DK171331B1
(en)
1996-09-09
NO864990D0
(en)
1986-12-10
GR3004903T3
(en)
1993-04-28
DK592186A
(en)
1987-06-12
JPS62223192A
(en)
1987-10-01
CN86108729A
(en)
1987-10-21
Similar Documents
Publication
Publication Date
Title
AU6687486A
(en)
1987-06-18
Solubilization of protein aggregates
AU7201287A
(en)
1987-09-28
Recombinant human endothelial cell growth factor
AU579595B2
(en)
1988-12-01
Enzyme-resistant immunomodulatory peptides
JPS6447389A
(en)
1989-02-21
Production of active protein
DE69534878D1
(en)
2006-05-11
NOVEL ADENOVIRAL VECTORS, PACKAGING CELL LINES, RECOMBINANT ADENOVIRES AND METHOD
GB8610600D0
(en)
1986-06-04
Transformation of trichoderma
BR9507678A
(en)
1997-09-23
Construction of dna recombinant expression vector cell process to produce an enzyme enzyme preparation enzyme use and culture
NZ320276A
(en)
1999-11-29
Method and preparations for stabilizing biological materials by drying methods without freezing
KR900700592A
(en)
1990-08-16
Soluble T-4 Derivative
ZA852900B
(en)
1985-11-27
The preparation of polypeptides having human gamma interferon activity
HUT68379A
(en)
1995-06-28
Method for modifying the cell, tissue or host tropism of a recombinant microorganism obtained this way and use thereof in medicine and veterinary medicine
AU1948788A
(en)
1989-01-04
Expression of immunologically active proteins of human b-lymphotropic virus
JPH0391479A
(en)
1991-04-17
Human protein c and/or protein having activated human protein c like activity
UA10281C2
(en)
2000-11-15
Method to obtain substance to treat pancreas diseases
MY103305A
(en)
1993-05-29
Productions of proteins in active forms
Legal Events
Date
Code
Title
Description
2000-03-16
PC
Assignment registered
Owner name:
NATINO NV
Free format text:
FORMER OWNER WAS: SOUTHERN CROSS BIOTECH PTY LTD.
2000-03-30
TH
Corrigenda
Free format text:
IN VOL 14, NO 7, PAGE(S) 1249-1250 UNDER THE HEADING ASSIGNMENTS REGISTERED THE NAME OF THE ASSIGNEE IN REGARD TO PATENT NUMBERS 597924, 599922, 612133, 617658, 618396, 647374 AND 664021 SHOULD READ NATINCO NV.
